Table 1 (abstract P040). Comparison of “flare” and “persistent ID” groups
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Flare n=67 (48,6%) | Persistent ID n=71 (51,4%) | All patients n=138 (100%) | p | |
|---|---|---|---|---|
Median age at disease onset, yrs median (min-max), IQR* | 3,8 (0,4-16,3) 5,2 | 6,9 (0,4-15) 8,6 | 5,1 (0,4-16) 6,4 | 0,02 |
Median age at diagnosis, yrs median (min-max), IQR* | 4,2 (0,5-16) 5,3 | 7,8 (0,8-15,7) 8,8 | 5,8 (0,5-16) 6,8 | 0,004 |
JIA subgroup n (%) | ||||
Oligoarticular JIA | 34 (61) | 22 (39) | 56 (40,6) | 0,007 |
Polyarticular JIA | 21 (46,7) | 24 (53,3) | 45 (32,6) | |
So JIA | 5 (20) | 20 (80) | 25 (18,1) | |
JPsA | 7 (58,3) | 5 (41,7) | 12 (8,7) | |
ANA positivity n (%) | 41 (61,2) | 26 (36,6) | 67 (48,5) | 0,004 |
CRP value at MTX initiation (mg/L) median (min-max), IQR* | 8 (0,2-222) 23,8 | 4,2 (0,02-193) 15 | 6,8 (0,02-222) 21 | 0,01 |